Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
Is screening for hepatitis B and hepatitis C useful in patients with recent-onset polyarthritis? The ESPOIR cohort study
Journal of Rheumatology, 07/02/09
Guennoc X et al. - Prevalence of hepatitis B (HBV) and C (HCV) in a population of patients with recent-onset polyarthritis was not greater than the general population in France. Routine HBV and HCV serological testing did not contribute to the diagnosis of RA, however serological testing before initiating immunosuppressive or hepatotoxic drugs is advisable.
Methods- An evaluation of seroprevalence of HBV and HCV in pts living in France with recent-onset polyarthritis suggesting RA
- 813 pts in ESPOIR cohort were screened for anti-HCV antibodies and HBs antigen
- Seroprevalence was 0.86% for HCV and 0.12% for HBV
- HCV-related arthritis was diagnosed in 0.5% pts; no patient had HBV-related arthritis
- HCV-seropositive pts had higher transaminase levels but only 2 pts had ASAT or ALAT levels >40 IU
- No difference for anti-CCP Abs, CRP, ESR, or other test
- HCV seroprevalence was higher in subgroup with history of blood transfusion vs other pts
- 2/7 HCV positive pts and single patient with confirmed hepatitis B infection were born in areas with higher prevalence of viral hepatitis
- Positive hepatitis status was known before study inclusion in 4/7 HCV-positive pts and in HBV-positive patient
Related Articles
The beneficial effects of a 3 week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: Results of the STIVEA trial
Annals of Rheumatic Diseases, 11/24/09
Relevance Score: 42%
Early treatment with and time on first Disease Modifying Anti-Rheumatic Drug predicts long-term function in patients with inflammatory polyarthritis
Annals of Rheumatic Diseases, 11/11/09
Relevance Score: 42%
Clinical, radiological, and biochemical characteristics in patients with diseases mimicking polymyalgia rheumatica
Clinical Interventions in Aging, 10/01/09
Relevance Score: 42%
Association of functional outcome with both personal- and area-level socioeconomic inequalities in patients with inflammatory polyarthritis
Arthritis Care and Research, 10/07/09
Relevance Score: 41%
Abnormal externally guided movement preparation in recent-onset schizophrenia is associated with impaired selective attention to external input
Psychiatry Research, 10/29/09
Relevance Score: 40%
Today in Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years
The Lancet, 12/15/09
Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy
Journal of the National Cancer Institute, 12/15/09
Associations between HLA Class I Alleles and Escape Mutations in the Hepatitis B Virus Core Gene in New Zealand-Resident Tongans
Journal of Virology, 12/15/09
Today in Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Association of medication attitudes with non-persistence and non-compliance with medication to prevent fractures
Osteoporosis International, 12/15/09
Human leukocyte antigen-G in ankylosing spondylitis and the response after tumour necrosis factor-&alpha blocker therapy
Rheumatology, 12/15/09
First-line DMARD choice in early rheumatoid arthritis - Do prognostic factors play a role?
Rheumatology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


